Epidemiology and etiology of community-acquired pneumonia
- PMID: 15555823
- PMCID: PMC7135665
- DOI: 10.1016/j.idc.2004.08.003
Epidemiology and etiology of community-acquired pneumonia
Abstract
The seriousness of community-acquired pneumonia (CAP), despite being a reasonably common and potentially lethal disease, often is under estimated by physicians and patients alike. CAP results in more than 10 million visits to physicians, 64 million days of restricted activity, and 600,000 hospitalizations. This article discusses the epidemiology and bacterial causes of CAP in immunocompetent adults and the severe acute respiratory syndrome coronavirus.
References
-
- Niederman M.S., McCrombs J.I., Unger A.N., Kumar A., Popovian R. The cost of treating community acquired pneumonia. Clin Ther. 1998;20:820–837. - PubMed
-
- Dixon R.E. Economic costs of respiratory tract infections in the United States. Am J Med. 1985;78:45–51. - PubMed
-
- National Center for Health Statistics. National hospital discharge survey: annual summary 1990. Vital Health Stat. 1998;13:1–225. - PubMed
-
- Marrie T.J., Durant H., Yates L. Community acquired pneumonia requiring hospitalization: a 5 year prospective study. Rev Infect Dis. 1989;11:586–599. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
